Intra-Cellular Therapies (Nasdaq: ITCI) is a drug-development company developing novel therapeutics for depression, schizophrania, Parkinson’s disease, Alzheimer’s disease, and other Central Nervous System (CNS) disorders.
Andrew Technologies is an early stage medical device company working to develop novel surgical instruments using its proprietary technology. Tom Albright Three South Haddon Avenue,
Indevus Pharmaceuticals is a publicly-traded biotechnology company focusing on developing and commercializing speciality pharmaceuticals. Through internal R&D and strategic partnerships, it is advancing the state-of-art
Clinical trial solutions that are founded in a future-ready, flexible, PEOPLE FIRST culture to deliver greater value for employees and client organizations. To learn more
Sword Diagnostics is commercializing a detection technology for clinical diagnostics and life sciences research that is much more sensitive than current technologies and is easily
Future of Ventilation Technology: Building the only breath support therapy designed to make breathing easier with a wearable device for people with respiratory disorders. The
Regenosine is developing first-in-class therapies for tissue regeneration. The purinergic system regulates and maintains tissue homeostasis. They have demonstrated that restoring adenosine levels in various
ReGelTec is developing an injectable hydrogel for minimally invasive treatment of chronic low back pain from degenerative disc disease. Learn more at https://regeltec.com
Redpoint Bio (OTCBB:RPBC) is a biotechnology company focused on developing more nutritious foods and beverages and new approaches to treating diabetes and obesity. Scott Horovitz
MEND is a clinical-grade nutrition that’s proven to support and enhance healing so that you can get back to optimal living. Learn more at https://mend.me
Kuiper founded by healthcare icon Dr. Andrew Pecora. Kuiper provides stem cell therapy for vascular deficits such as chronic limb ischemia and coronary microvascular dysfunction.
EpiBone is on a mission to use groundbreaking research to transform skeletal repair. Visit https://www.epibone.com/ to learn more.
CytoSorbents (OTCBB:CTSO) is a publicly traded medical device company that has developed CytoSorb, a patented technology designed to treat potentially fatal “cytokine storm,” also known
Colby Pharmaceuticals acquired Othera Pharmaceuticals in September 2012. Colby is a clinical company developing proprietary drug molecules targeting diseases related to oxidative stress, immunity, cancer,
PO Box 307
Summit, NJ 07902
+1-856-273-6800
We invest in the most promising early-stage, rapid-growth technology companies in the Mid-Atlantic region.
© 2023 Tech Council Ventures, LLC. All Rights Reserved.
Website designed by Lookit® Design , powered by Lookit® QuikSite.
© 2023 Tech Council Ventures, LLC.
All Rights Reserved.
Website designed by Lookit® Design ,
powered by Lookit® QuikSite.
